This study is collecting information from patients who are at a high risk of developing pancreatic cancer based on family history or genetic mutations to see if a pancreatic cancer screening blood test can be developed.
Pancreatic cancer is difficult to detect in its early stages, as it has no early symptoms. Imaging using MRI or CT scans is the standard way it’s detected but imaging is not always sensitive or specific enough and it’s expensive to do. This study is testing a pancreatic cancer screening blood test that looks for particular immune system responses that might indicate the presence of pancreatic cancer. Patient enrolled in this study will have blood tests every 6 months and an imaging test yearly
What we're hoping for
We hope to find out if this lab test can detect pancreatic cancer and if it is better than current methods of detecting cancer.
ClinicalTrials.gov Identifier: NCT03693378